CAN BIDEN REIN IN ISRAEL?
Newsweek US|October 27, 2023
As Middle East wars escalate, U.S. presidents usually act to contain hostilities. This time looks different
DANIEL BUSH
CAN BIDEN REIN IN ISRAEL?

AMERICA'S RESPONSE TO OUTBREAKS OF violence in the Middle East conflict has followed the same pattern for decades: U.S. presidents from Richard Nixon to Bill Clinton to Barack Obama pledged support for Israel, then urged restraint and eventually called for an end to the fighting as the death toll rose.

But President Joe Biden faces a unique combination of factors that may constrain his ability to rein in the war between Israel and Hamas-including the unprecedented scale of Hamas's attack, the growing threat of a regional war, a hostage crisis involving American citizens and growing calls for de-escalation from progressive Democrats who have become increasingly vocal in their support for Palestinians in recent years-and whose support is vital to Biden's 2024 re-election campaign.

As Israel's newly formed emergency wartime government prepares for a likely ground invasion of the Gaza Strip, it's unclear when Biden may step in to try to de-escalate the conflict, or how much leverage he'll have to rein in Israel once the toll on civilians starts to rise.

"Biden faces more of a challenge than U.S. presidents have in years" in containing a war in the Middle East that involves Israel from spinning out of control, John McLaughlin, who served as acting director of the CIA under George W. Bush, tells Newsweek.

"The American task at this point is to keep it from going beyond where it is," McLaughlin says. "Once you get past this phase, you can start thinking about de-escalation."

Denne historien er fra October 27, 2023-utgaven av Newsweek US.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra October 27, 2023-utgaven av Newsweek US.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA NEWSWEEK USSe alt
AMERICA'S BEST LOYALTY PROGRAMS 2025
Newsweek US

AMERICA'S BEST LOYALTY PROGRAMS 2025

LOYALTY PROGRAMS HAVE BECOME A CORNERSTONE of the modern shopping experience, offering perks and rewards designed to keep customers returning for more.

time-read
3 mins  |
February 21, 2025
Winning the Global Game
Newsweek US

Winning the Global Game

The U.S. holds more cards than China. Whether we keep our strategic advantage depends on how we play our hand

time-read
3 mins  |
February 21, 2025
Solar Power
Newsweek US

Solar Power

Scientists' creation of a record-breaking \"artificial sun\" brings nuclear fusion energy a step closer to being a commercial reality

time-read
2 mins  |
February 21, 2025
Trump vs. Deep State
Newsweek US

Trump vs. Deep State

The president and his efficiency chief Elon Musk have brought in a wave of policies affecting federal employees' jobs. Government workers spoke to Newsweek about the impact

time-read
6 mins  |
February 21, 2025
MAD ABOUT THE GIRL
Newsweek US

MAD ABOUT THE GIRL

AS RENÉE ZELLWEGER REPRISES THE ICONIC CHARACTER, BRIDGET JONES' CREATOR - AND MILLIONS OF FANS, COULDN'T BE HAPPIER

time-read
10+ mins  |
February 21, 2025
Armed and Dangerous
Newsweek US

Armed and Dangerous

A Ukrainian colonel reveals how North Korean soldiers compared with their Russian allies

time-read
4 mins  |
February 21, 2025
Patrick Gibson
Newsweek US

Patrick Gibson

WHEN YOU TAKE ON A ROLE THAT SOMEBODY ELSE MADE FAMOUS, IT'S not easy.

time-read
2 mins  |
February 21, 2025
The AI Will See You Now
Newsweek US

The AI Will See You Now

A light-hearted study into artificial intelligence's ability to perform cognitive tasks has raised questions around the roles of AI and doctors in health care

time-read
6 mins  |
February 21, 2025
Jasmin Savoy Brown
Newsweek US

Jasmin Savoy Brown

SHOWTIME'S YELLOWJACKETS IS REALLY TWO shows in one.

time-read
2 mins  |
February 21, 2025
BIOTECH: Blood, Sweat and Tears
Newsweek US

BIOTECH: Blood, Sweat and Tears

Nine years in the making, Truvian's quick tabletop blood test promises to deliver where Theranos famously couldn't

time-read
6 mins  |
February 14, 2025